BC Innovations | Jan 7, 2016
Distillery Therapeutics

Therapeutics: Macrophage inflammatory protein 3 (CCL23; MPIF1)

Cancer INDICATION: Breast cancer Cell culture and mouse studies suggest inhibiting CCL23 could help treat metastatic breast cancer. In patients, levels of CCL23 in peripheral blood mononuclear cells correlated with poor survival. In a mouse...
BC Innovations | Feb 12, 2009
Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Chronic myelogenous leukemia (CML) Interferon regulatory factor 8 (IRF8; ICSBP); macrophage inflammatory protein 3 (CCL15); macrophage inflammatory protein 5 (CCL23) Studies...
Items per page:
1 - 2 of 2